The T-cell receptor (TCR-) and FcR-␥ chains play a critical role in mediating signal transduction. We have previously described HIV glycoprotein 120 (gp120)-specific chimeric immune receptors (CIRs) in which the extracellular domain of CD4 is linked to the signaling domain of (CD4) 
Introduction
We have previously described HIV glycoprotein 120 (gp120)-specific chimeric immune receptors (CIRs) in which the cytoplasmic domain of either the T-cell receptor (TCR-) or the FcR-␥ chain is linked to the extracellular and transmembrane domains of the human CD4 receptor. [1] [2] [3] [4] [5] Mature CD4-expressing T lymphocytes generated ex vivo by retroviral transduction are capable of highly efficient and specific cytolysis of both HIV-infected primary cells and HIVgp120-expressing tumors in vitro, 1, 4 and clinical trials involving adoptive transfer of autologous CD4-transduced T cells in HIV-infected patients have been undertaken. 6, 7 In vivo development of CIR-modified T cells from transplanted hematopoietic stem cells (HSCs) may have some advantages over adoptive transfer of ex vivo-transduced mature T cells, because the former bypasses the need for extensive ex vivo cell expansion and may improve T-cell function in vivo. Our previous studies have shown that severe combined immunodeficient (SCID) mice (which lack T and B cells) rapidly reconstitute CD4-expressing myeloid and natural killer (NK) cells following transplantation with retrovirally transduced syngeneic bone marrow. 3 Furthermore, such SCID mice that received CD4 transplants are protected from a lethal dose of HIVgp120-expressing leukemia cells. 3 One of the many potential barriers to implementation of a bone marrow transplantation (BMT) approach for generating functional CD4 T cells is the impact, if any, of retroviral-driven CIR expression early in hematopoiesis on T-cell development. The affinity of the human CD4 receptor for murine and human major histocompatibility complex class II (MHCII) is insufficient for activation of CD4/␥-expressing T cells. 1, 2, [8] [9] [10] [11] However, the consequences of such lowaffinity interactions on lymphoid development have not been examined.
T cells develop from HSC-derived progenitor cells that migrate to the thymus. Subsequent thymocyte development is regulated by sequential expression of the pre-TCR 12,13 and the mature ␣␤TCR, 14,15 both of which are multimeric complexes that rely on the associated invariant CD3 and chains for transmitting essential survival, differentiation, and proliferation signals. The most immature thymocytes reside within the CD4 Ϫ CD8 Ϫ CD3 Ϫ triplenegative (TN) population, which comprises only about 1% to 2% of total thymocytes. The TN population itself can be divided into the sequential subsets TN1 (CD44 ϩ 25 Ϫ ), TN2 (CD44 ϩ 25 ϩ ), TN3 (CD44 Ϫ 25 ϩ ), and TN4 (CD44 Ϫ 25 Ϫ ). 12, 13 The pre-TCR permits progression from TN3 through to the CD4 ϩ CD8 ϩ double-positive (DP) stage, whereas the ␣␤TCR drives subsequent selection to mature CD4 ϩ and CD8 ϩ single-positive cells. The studies described in this report were designed to determine the impact, if any, of CD4/␥ CIR expression on thymocyte development in the setting of BMT.
Study design Vectors
Retroviral vectors expressing CD4del, CD4, and CD4␥ CIRs via an internal phosphoglycerate kinase (pgk) promoter have been described previously. 2, 3, 5, 16 
Mice
The MHCII-deficient (MHCII Ϫ ) mice possess a disruption of the MHC class II Ab ␤ gene (B6.129-Abb tm1 ; Taconic, Germantown, MD) and therefore do not express surface MHCII in the C57BL/6 background. Wild-type C57BL/6 mice (Taconic) were used as MHCII ϩ recipients in experiments involving donor marrow from MHCII Ϫ mice.
Flow cytometry
Antibodies (Pharmingen, San Diego, CA) used to stain peripheral blood and thymocytes are described in the figure legends. Stained cells were analyzed on a FACScan cytometer (Becton Dickinson, San Jose, CA).
Results and discussion
Bone marrow was isolated from C3H mice and retrovirally transduced with CD4, CD4␥, or a signaling-defective CIR (CD4del) as previously described. 3, 5 Surface CIR expression on transduced bone marrow cells before infusion is shown in Figure 1A . Although the percentage of cells expressing CD4 and CD4␥ was similar, the mean intensity of expression was considerably higher for the CD4 and CD4del receptors as seen in previous studies. 5 The transduced bone marrow was subsequently transplanted into sublethally irradiated C3H mice via tail-vein injection.
Peripheral blood was isolated from reconstituted animals at approximately 6 weeks after transplantation and analyzed by 2-color flow cytometry using monoclonal antibodies against human CD4 and the following mouse cell lineage markers: GR-1 (granulocytes); B220 (B cells); 5E6 (NK cells), or CD3 (T cells; Figure 1B) . CD4, CD4␥, and CD4del were expressed on granulocytes and NK cells at similar frequencies, as previously described for SCID mice following BMT. 5 Although similar levels of expression were observed in B cells for all 3 receptors, T cells expressing CD4 or CD4␥ were not detected. In contrast, expression of the signalingdefective CIR, CD4del, was retained on this lineage.
The differential expression of CD4del and CD4/␥ in mature T lymphocytes prompted us to examine CIR expression during thymocyte development. Thymocytes were harvested from mice that had received either CD4-or CD4del-transduced bone marrow 6 weeks before, and TN2, TN3, TN4, and TP (triple-positive) CD3 ϩ CD4 ϩ CD8 ϩ populations were examined for human CD4 expression by flow cytometry as described in Figure 1C . Low levels of TN1 cells precluded analysis of this particular subset. Whereas CD4del expression was observed at similarly high levels at every stage of thymocyte development examined, CD4 expression was not detected at any stage. Similar results were observed for CD4␥ (data not shown). In contrast to the T-cell lineage, CD4 expression was detected at comparable levels to that of CD4del in B, myeloid, and NK cells ( Figure 1B-C) in peripheral blood samples isolated from the same CD4-marrow animal that underwent transplantation.
To determine whether engagement of CD4 or CD4␥ (CD4/␥) by MHCII was indeed responsible for the failure of CD4/␥-bearing thymocyte development, immune reconstitution was examined in mice lacking MHCII expression. Specifically, bone marrow derived from C57BL/6 mice lacking expression of MHCII (MH-CII Ϫ ) was transduced with CD4, CD4␥, or CD4del, and transplanted into syngeneic (MHCII Ϫ ) or congenic (MHCII ϩ ) wild-type recipients. As before, peripheral blood was harvested from reconstituted mice approximately 6 weeks after transplantation, and B-and T-cell lineages examined for human CD4 expression by flow cytometry (Figure 2A) . Analysis of peripheral blood isolated from MHCII ϩ or MHCII Ϫ recipients revealed expression of each of the 3 receptors on B cells (Figure 2A ), myeloid cells, and NK cells (data not shown) as expected. Consistent with the experiment summarized in Figure 1 using C3H mice, T cells expressing the CD4del receptor, but not CD4 or CD4␥, were present in reconstituted MHCII ϩ recipients. In striking contrast, T cells from MHCII Ϫ recipients expressed either CD4 or CD4␥ receptors at levels comparable to those of the CD4del receptor. Flow cytometric For personal use only. on October 17, 2017 . by guest www.bloodjournal.org From analysis of thymocytes isolated from the MHCII Ϫ recipient mice in Figure 2B revealed that CD4-expressing TN2, TN3, TN4, and TP thymocytes could now be detected at equivalent frequencies to the CD4del subsets ( Figure 2C ).
In summary, we have shown that development of CD4/␥-bearing T cells from transplanted HSCs is arrested prior to the TN2 (CD44 ϩ CD25 ϩ ) stage in normal mice. The developmental block is specific for the T lineage because myeloid, NK, and B cells are unaffected. In addition, we have shown that T-lineage arrest is dependent on the signaling domain of either or ␥ (because CD4del-expressing T cells develop normally), and on expression of the CD4 ligand, MHCII. The process by which HSCs commit to the T-lymphoid lineage is poorly understood, particularly during adult steady-state hematopoiesis. Several studies suggest that TN1 cells in the thymus arise from, or are equivalent to, common lymphocyte precursors (CLPs) found in bone marrow. 17, 18 TN1 cells (and CLPs) have lost myeloid potential, but can still develop into lymphocytes (T, B, and NK cells). 17, 18 By the TN2 stage, however, the potential to develop into B and NK cells has also been lost. Our current hypothesis is that /␥-mediated signal transduction occurs in response to CD4/␥-MHCII engagement during the CLP/ TN13TN2 transition. The TN33TN4 transition is mediated by pre-TCR signaling via the associated immunoreceptor tyrosinebased activation motif (ITAM)-bearing CD3/ chains. [19] [20] [21] [22] [23] Presumably, premature or aberrant ITAM-mediated signal transduction by CD4/␥ during the CLP/TN13TN2 transition arrests T-lineage commitment or differentiation of committed T-cell precursors. This hypothesis is consistent with recent data from our laboratory showing that CD4 is expressed at high levels on TN thymocytes when under the transcriptional control of the CD2 enhancer instead of the constitutively active pgk promoter of the retroviral vector (manuscript in preparation). Despite the presence of only a single ITAM, CD4␥ is as effective as CD4 in mediating this developmental defect. The FcR-␥ chain is known to be expressed in normal DN thymocytes and has been implicated in the development of certain T-cell subsets. 24, 25 The mechanisms driving lineage commitment during the CLP/TN13TN2 transition remain obscure. Studies are now underway to determine the specific step in this complex pathway at which CD4/␥-induced arrest occurs, and to further dissect the process of T-lineage determination.
